Chennai, November 12, 2014: TAKE Solutions Ltd. [BSE: 532890 | NSE: TAKE], a global business technology solutions provider with significant focus across two principal business areas, namely Life Sciences (LS) and Supply Chain Management (SCM) domains, today, announced the financial results for the second quarter of FY 2015. The Company has posted revenue of INR 1,690 million for this quarter, a 4.6% increase over the previous quarter. The Board of Directors of the Company has declared an interim dividend of Rs. 0.30/- per equity share (30%, on a face value of Re. 1/- per share) for the period ended September 30, 2014.
The Board also appointed its first woman Director Ms. Uma Ratnam Krishnan who brings with her a diverse experience of 27 years in the Financial Services sector. With a deep understanding of customers, markets, business drivers and partners, Ms. Krishnan has built successful industry networks with key stakeholders.
Srinivasan H.R., Vice-Chairman and Managing Director, TAKE Solutions said, “The strategy to emphasize on the Life Sciences business envisaged by the management at the start of the previous financial year has slowly but steadily started showing results. Our focus will be to continue enhancement of our position in the Life Sciences space. Additionally, we are also increasingly investing both time and money in improving our go-to-market strategy which will enable us to acquire new clients and expand our offerings to the existing clients”.
About TAKE Solutions
TAKE Solutions Ltd. [BSE: 532890 | NSE: TAKE] is a leading global business technology company with domain expertise in Life Sciences (LS) and Supply Chain Management (SCM). TAKE provides cost-effective and comprehensive solutions for enterprises across diverse sectors including pharmaceuticals, high technology, consumer packaged goods, oil/gas, and automotive. TAKE’s SCM product suite includes distinct technology with embedded IP that spans enterprise mobility, trading partner collaboration, and material tracking. In the LS domain, TAKE offers IP-based software and extensive knowledge-based solutions to enable efficient clinical, regulatory, safety and commercialization processes. TAKE has been recognized as a ‘Leader’ in IDC Health Insights’ “IDC MarketScape: Worldwide Life Science Drug Safety Services 2013 Vendor Assessment”. TAKE’s global headquarters is in Chennai, India; its U.S. headquarters is located in Princeton, New Jersey. TAKE has a proven track record as a trusted partner in delivering world-class solutions to more than 400 customers worldwide. For more information, please visit www.takesolutions.com
contacts:
Annapoorna K., TAKE Solutions Ltd., This email address is being protected from spambots. You need JavaScript enabled to view it., Tel: +91 44 2435 7359/60
Murugan G, 20:20 MSL, This email address is being protected from spambots. You need JavaScript enabled to view it., Mobile: +91 98412 78904
